Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer

Hepato-Gastroenterology

Volumn 61, Issue 133, 2014, Pages 1359-1362

  Kobayashi, Takashi ^a   Kawakami, Masayo ^a   Hara, Yoshiaki ^a   Shioiri, Sadaaki ^c   Yasuno, Masamichi ^a   Teruya, Masanori ^b   Kaminishi, Michio ^b  

^a TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^b Kodaira shi   (Japan)

^c NONE

Author keywords

Carcinoembryonic antigen; Colorectal liver metastasis; Glasgow prognostic score; Postoperative outcomes

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; ALB PROTEIN, HUMAN; SERUM ALBUMIN;

AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COLORECTAL LIVER METASTASIS; FEMALE; GLASGOW PROGNOSTIC SCORE; HUMAN; HYPOALBUMINEMIA; LIVER RESECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; BLOOD; COLORECTAL TUMOR; COMORBIDITY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME;

AGED; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; HYPOALBUMINEMIA; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906987232     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13335     Document Type: Article

References (29)

1. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery. 1988;103:278-288.
2. Heslin MJ, Medina-Franco H, Parker M, et al. Colorectal hepatio metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg. 2001;136:318-323. (Pubitemid 32204969)
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19:59-71.
4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318.
5. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715-722.
6. Jarnagin WR, Conlon K, Bodniewicz J, et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer. 2001;91:1121-1128. (Pubitemid 32295417)
7. Minagawa M, Yamamoto J, Kosuge T, et al. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg. 2007;142:269-276. (Pubitemid 46457054)
8. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545. (Pubitemid 32173595)
9. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867. (Pubitemid 36019639)
10. Roxburgh CS, Salmond JM, Horgan PG, et al. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 2009;249:788-793.
11. Ishizuka M, Nagata H, Takagi K, et al. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047-1051. (Pubitemid 350179198)
12. McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90: 215-219. (Pubitemid 36237897)
13. Crumley AB, McMillan DC, McKeman M, et al. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer. 2006;94:637-641. (Pubitemid 43361893)
14. McMillan DC, Elahi MM, Sattar N, et al. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer. 2001;41:64-69. (Pubitemid 34666222)
15. Leitch EF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97:1266-1270. (Pubitemid 350035815)
16. Kobayashi T, Teruya M, Kishiki T, et al. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery. 2008;144:729-735.
17. Hilmy M, Bartlett JM, Underwood MA, McMillan DC. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer. 2005;92:625-627. (Pubitemid 40460593)
18. Jamieson NB, Glen P, McMillan DC, et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer. 2005;92:21-23. (Pubitemid 40188430)
19. Crumley AB, McMillan DC, McKeman M, et al. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006;94:1568-1571. (Pubitemid 43924914)
20. Forrest LM, McMillan DC, McArdle CS, et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90:1704-1706. (Pubitemid 38725637)
21. Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg. 2006;141:1006-1012. (Pubitemid 44583259)
22. Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008;32:93-103. (Pubitemid 50004245)
23. Ishizuka M, Kita J, Shimoda M, et al. Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol. 2009;100:38-42.
24. Canna K, McArdle PA, McMillan DC, et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2005;92:651-654. (Pubitemid 40460599)
25. Scott HR, McMillan DC, Forrest LM, et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002;87:264-267.
26. McMillan DC, Scott HR, Watson WS, et al. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer. 1998;31:101-105. (Pubitemid 28428069)
27. Bromwich E, McMillan DC, Lamb GW, et al. The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer. 2004;91:1236-1238. (Pubitemid 39424780)
28. Masi G, Loupakis F, Pollina L, et al. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009;249:420-425.
29. Poston GJ, Figueras J, Giuliante F, et al. Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol. 2008;26:4828-4833.